Systematic review of 24 studies in adults with non-cirrhotic chronic hepatitis B: nucleos(t)ide analogues were linked to lower HCC risk with HBV DNA ≥20 000 IU/mL (aHR 0.39, non-randomised), with no significant effect below 20 000 IU/mL.
Meta-analysisn = 24 studies
Im et al. Efficacy of antiviral therapy in adults with chronic hepatitis B according to baseline hepatitis B virus DNA and alanine aminotransferase concentrations: a systematic review and meta-analysis